Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bostick: If the inflation rate drops faster, interest rates may be cut ahead of schedule

Bostick: If the inflation rate drops faster, interest rates may be cut ahead of schedule

Bitget2024/01/19 00:15

Atlanta Federal Reserve Chairman Bostic stated that if there is "convincing" evidence in the next few months showing inflation falling faster than he expected, he would be open to earlier rate cuts. He had previously said that he expects it would be appropriate for the Fed to lower benchmark interest rates in the second half of this year, but on Thursday he said, "If we continue to see more unexpected downturns in data, I might confidently advocate for normalizing interest rates before the third quarter. But the evidence needs to be convincing." However, Bostic added that overall situation faced by the Fed "requires caution". He said: "Cutting rates too early could trigger a surge in demand and thus put pressure on price increases." “We don't want to disrupt our great progress so far in bringing inflation back on target.” He mentioned global conflicts may once again disrupt supply chains and cause inflation rise.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12